Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Resolution of congenital nasolacrimal duct obstruction with nonsurgical management.

Pediatric Eye Disease Investigator Group.

Arch Ophthalmol. 2012 Jun;130(6):730-4. doi: 10.1001/archophthalmol.2012.454.

2.

Probing for congenital nasolacrimal duct obstruction.

Petris C, Liu D.

Cochrane Database Syst Rev. 2017 Jul 12;7:CD011109. doi: 10.1002/14651858.CD011109.pub2. Review.

PMID:
28700811
3.

A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction.

Pediatric Eye Disease Investigator Group.

Arch Ophthalmol. 2012 Dec;130(12):1525-33. doi: 10.1001/archophthalmol.2012.2853.

4.

A comparison of treatment approaches for bilateral congenital nasolacrimal duct obstruction.

Lee KA, Chandler DL, Repka MX, Melia M, Beck RW, Summers CG, Frick KD, Foster NC, Kraker RT, Atkinson S; PEDIG.

Am J Ophthalmol. 2013 Nov;156(5):1045-50. doi: 10.1016/j.ajo.2013.06.014. Epub 2013 Aug 15.

5.

Office probing for treatment of nasolacrimal duct obstruction in infants.

Miller AM, Chandler DL, Repka MX, Hoover DL, Lee KA, Melia M, Rychwalski PJ, Silbert DI; Pediatric Eye Disease Investigator Group, Beck RW, Crouch ER 3rd, Donahue S, Holmes JM, Quinn GE, Sala NA, Schloff S, Wallace DK, Foster NC, Frick KD, Golden RP, Lambert SR, Tien DR, Weakley DR Jr.

J AAPOS. 2014 Feb;18(1):26-30. doi: 10.1016/j.jaapos.2013.10.016.

6.

Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan.

Hung CH, Chen YC, Lin SL, Chen WL.

Pediatr Neonatol. 2015 Dec;56(6):402-7. doi: 10.1016/j.pedneo.2015.04.001. Epub 2015 Apr 23.

7.

Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age.

Pediatric Eye Disease Investigator Group, Repka MX, Melia BM, Beck RW, Atkinson CS, Chandler DL, Holmes JM, Khammar A, Morrison D, Quinn GE, Silbert DI, Ticho BH, Wallace DK, Weakley DR Jr.

J AAPOS. 2008 Oct;12(5):445-50. doi: 10.1016/j.jaapos.2008.03.005. Epub 2008 Jul 2.

8.

Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age.

Pediatric Eye Disease Investigator Group, Repka MX, Melia BM, Beck RW, Chandler DL, Fishman DR, Goldblum TA, Holmes JM, Perla BD, Quinn GE, Silbert DI, Wallace DK.

J AAPOS. 2008 Oct;12(5):451-5. doi: 10.1016/j.jaapos.2008.07.001.

9.

The natural process of congenital nasolacrimal duct obstruction and effect of lacrimal sac massage.

Karti O, Karahan E, Acan D, Kusbeci T.

Int Ophthalmol. 2016 Dec;36(6):845-849. Epub 2016 Mar 7.

PMID:
26948127
10.

Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years.

Pediatric Eye Disease Investigator Group, Repka MX, Chandler DL, Beck RW, Crouch ER 3rd, Donahue S, Holmes JM, Lee K, Melia M, Quinn GE, Sala NA, Schloff S, Silbert DI, Wallace DK.

Ophthalmology. 2008 Mar;115(3):577-584.e3. Epub 2007 Nov 8.

11.

[Comparison of balloon catheter dilatation and silicon intubation as the secondary treatment for congenital nasolacrimal duct obstruction after failed primary probing].

Hu M, Wu Q, Fan YW, Cao WW, Lin Q, Yu G.

Zhonghua Yan Ke Za Zhi. 2016 Feb;52(2):123-8. doi: 10.3760/cma.j.issn.0412-4081.2016.02.009. Chinese.

PMID:
26906708
12.

Age-based comparison of successful probing in Nepalese children with nasolacrimal duct obstruction.

Limbu B, Akin M, Saiju R.

Orbit. 2010 Feb;29(1):16-20. doi: 10.3109/01676830903207844.

PMID:
20302404
13.

Congenital nasolacrimal duct obstruction: natural history and the timing of optimal intervention.

Paul TO, Shepherd R.

J Pediatr Ophthalmol Strabismus. 1994 Nov-Dec;31(6):362-7. Review.

PMID:
7714699
14.

Balloon catheter dilation and nasolacrimal duct intubation for treatment of nasolacrimal duct obstruction after failed probing.

Repka MX, Chandler DL, Holmes JM, Hoover DL, Morse CL, Schloff S, Silbert DI, Tien DR; Pediatric Eye Disease Investigator Group.

Arch Ophthalmol. 2009 May;127(5):633-9. doi: 10.1001/archophthalmol.2009.66.

15.

Repeat probing for treatment of persistent nasolacrimal duct obstruction.

Pediatric Eye Disease Investigator Group, Repka MX, Chandler DL, Bremer DL, Collins ML, Lee DH.

J AAPOS. 2009 Jun;13(3):306-7. doi: 10.1016/j.jaapos.2009.02.008.

16.

A symptom survey and quality of life questionnaire for nasolacrimal duct obstruction in children.

Holmes JM, Leske DA, Cole SR, Chandler DL, Repka MX; Nasolacrimal Duct Obstruction Questionnaire Study Group, Silbert DI, Tien DR, Bradley EA, Sala NA, Levin EM, Hoover DL, Klimek DL, Mohney BG, Laby DM, Lee KA, Enzenauer RW, Bacal DA, Mills MD, Beck RW; Pediatric Eye Disease Investigator Group.

Ophthalmology. 2006 Sep;113(9):1675-80. Epub 2006 Jul 7.

17.

Cost-effectiveness of 2 approaches to managing nasolacrimal duct obstruction in infants: the importance of the spontaneous resolution rate.

Frick KD, Hariharan L, Repka MX, Chandler D, Melia BM, Beck RW; Pediatric Eye Disease Investigator Group (PEDIG).

Arch Ophthalmol. 2011 May;129(5):603-9. doi: 10.1001/archophthalmol.2011.80.

18.

Monocanalicular silastic intubation for the initial correction of congenital nasolacrimal duct obstruction.

Engel JM, Hichie-Schmidt C, Khammar A, Ostfeld BM, Vyas A, Ticho BH.

J AAPOS. 2007 Apr;11(2):183-6. Epub 2007 Feb 15.

PMID:
17307001
19.

Success rates of primary probing for congenital nasolacrimal obstruction in children.

Arora S, Koushan K, Harvey JT.

J AAPOS. 2012 Apr;16(2):173-6. doi: 10.1016/j.jaapos.2011.12.151.

PMID:
22525175
20.

A simple and evolutional approach proven to recanalise the nasolacrimal duct obstruction.

Chen D, Ge J, Wang L, Gao Q, Ma P, Li N, Li DQ, Wang Z.

Br J Ophthalmol. 2009 Nov;93(11):1438-43. doi: 10.1136/bjo.2008.149393. Epub 2009 May 4.

Supplemental Content

Support Center